AVTX Avalo Therapeutics, Inc.
Healthcare$16.02-2.02%ClosedMarket Cap: $180.9M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$47.14
Target (Median)
$48.00
Target Range
$34.00 - $60.00
Upside from current price: 194.3%
Rating Distribution
2 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Mizuho | maintain | Outperform | Outperform |
| 2026-05-14 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-14 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-05-14 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-11 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-05-06 | BTIG | maintain | Buy | Buy |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-24 | BTIG | maintain | Buy | Buy |
| 2026-01-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-29 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.11 | $1.0M | 9 |
| Sun Dec 31 | $-2.88 | $13.9K | 6 |
| Mon Dec 31 | $-2.44 | $11.1M | 4 |
| Tue Dec 31 | $-1.31 | $106.5M | 2 |